Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

NCT01110733 is registered in ClinicalTrials.gov with Acrotech Biopharma Inc. as lead sponsor.

NCT NCT01110733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01110733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Lead sponsor
Acrotech Biopharma Inc.
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
December 31, 2019
Enrollment
3,000 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral t-cell lymphoma